The use of ivabradine in a patient with idiopathic ventricular arrhythmia originating from the left ventricular summit
JOURNAL OF ELECTROCARDIOLOGY, cilt.71, ss.32-36, 2022 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 71
- Basım Tarihi: 2022
- Doi Numarası: 10.1016/j.jelectrocard.2021.12.010
- Dergi Adı: JOURNAL OF ELECTROCARDIOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
- Sayfa Sayıları: ss.32-36
- Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır
Özet
Idiopathic ventricular arrhythmias (VA) are common and treatment options include anti-arrhythmic drugs (AAD) or catheter ablation. Patients presenting with idiopathic VA which is originating from the left ventricular summit (LVS) poses a particular challenge as the success for catheter ablation is low and AAD's may not be used long-term due to side effects. Ivabradine is an inhibitor of funny current (If) in cardiac pacemaker cells by blocking hyperpolarization-activated cyclic nucleotide-gated (HCN). In the present case, we reported the use of ivabradine in treatment of idiopathic VA which was originated from LVS and was resistant to multiple AAD's and catheter ablation. (c) 2022 Elsevier Inc. All rights reserved.